Residents of the 20 Republican-led states that are challenging the Affordable Care Act (ACA)'s protections for people with preexisting medical conditions have the most to lose; House Ways and Means Committee Chairman Kevin Brady, R-Texas, is in talks with HHS about ways to restart ACA payments; Judge Brett M. Kavanaugh ruled in a case that paved the way for hospitals to seek more money from Medicare.
Residents of the 20 Republican-led states that are challenging the Affordable Care Act (ACA)'s protections for people with preexisting medical conditions have the most to lose if the case is decided in the states' favor, Kaiser Health News reported. Those states challenged the constitutionality of the ACA in federal court in February. In June, Attorney General Jeff Sessions and the Department of Justice made the unusual decision not to defend key portions of the law against this legal challenge. Nine of the 11 states have the highest rates of preexisting conditions among adults under 65.
House Ways and Means Committee Chairman Kevin Brady, R-Texas, is in talks with HHS about ways to restart ACA payments that the administration abruptly suspended this month, The Hill reported. The Trump administration’s suspension of $10.4 billion in payments to insurers this month set off warnings of rising premiums and outrage from Democrats who said it was further evidence that the GOP is trying to undermine the ACA.
Judge Brett M. Kavanaugh, President Donald Trump’s choice for the Supreme Court, ruled in June in a federal appeals court case that paved the way for hospitals to seek more money from Medicare, based on evidence that the government has been using faulty data to calculate costs since 1983, The New York Times reported. The federal government tried to bar their claims, saying hospitals should not be able to challenge factual determinations made many years ago. But the United States Court of Appeals for the District of Columbia Circuit agreed with the hospitals, saying Medicare’s policy would require “the perpetual use of even demonstrably erroneous” information.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More